Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages
Top Cited Papers
- 19 June 2019
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 32 (3)
- https://doi.org/10.1128/cmr.00135-18
Abstract
Extraintestinal pathogenic Escherichia coli (ExPEC) strains are responsible for a majority of human extraintestinal infections globally, resulting in enormous direct medical and social costs. ExPEC strains are comprised of many lineages, but only a subset is responsible for the vast majority of infections. Few systematic surveillance systems exist for ExPEC. To address this gap, we systematically reviewed and meta-analyzed 217 studies (1995 to 2018) that performed multilocus sequence typing or whole-genome sequencing to genotype E. coli recovered from extraintestinal infections or the gut. Twenty major ExPEC sequence types (STs) accounted for 85% of E. coli isolates from the included studies. ST131 was the most common ST from 2000 onwards, covering all geographic regions. Antimicrobial resistance-based isolate study inclusion criteria likely led to an overestimation and underestimation of some lineages. European and North American studies showed similar distributions of ExPEC STs, but Asian and African studies diverged. Epidemiology and population dynamics of ExPEC are complex; summary proportion for some STs varied over time (e.g., ST95), while other STs were constant (e.g., ST10). Persistence, adaptation, and predominance in the intestinal reservoir may drive ExPEC success. Systematic, unbiased tracking of predominant ExPEC lineages will direct research toward better treatment and prevention strategies for extraintestinal infections.Keywords
This publication has 204 references indexed in Scilit:
- Comparison of Adhesin Genes and Antimicrobial Susceptibilities between Uropathogenic and Intestinal Commensal Escherichia coli StrainsPLOS ONE, 2013
- Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6-Year PeriodJournal of Korean Medical Science, 2013
- Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremiaJournal of Infection, 2011
- National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in SpainJournal of Antimicrobial Chemotherapy, 2011
- Characteristics of infections caused by extended-spectrum β-lactamase–producing Escherichia coli from community hospitals in South AfricaDiagnostic Microbiology and Infectious Disease, 2011
- Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from KoreaJournal of Antimicrobial Chemotherapy, 2011
- Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest SpainInternational Journal of Antimicrobial Agents, 2011
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in KoreaJournal of Infection, 2010
- Clonal Composition ofEscherichia coliCausing Community-Acquired Urinary Tract Infections in the State of Rio de Janeiro, BrazilMicrobial Drug Resistance, 2009